Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-14-000091
Filing Date
2014-08-05
Accepted
2014-08-05 17:31:44
Documents
1
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_140727429352512.html 4  
1 FORM 4 wf-form4_140727429352512.xml 4 4205
  Complete submission text file 0000920465-14-000091.txt   5582
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 675765 RANCHO SANTA FE CA 92067
Business Address
Zarrabian Saiid (Reporting) CIK: 0001495521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 141017255